BI
Boulegeris Investments’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-53,248
| Closed | -$2.95M | – | 8 |
|
|
2018
Q2 | $2.95M | Buy |
53,248
+3,970
| +8% | +$220K | 1.47% | 18 |
|
|
2018
Q1 | $3.12M | Buy |
49,278
+290
| +0.6% | +$18.3K | 1.71% | 18 |
|
|
2017
Q4 | $3M | Sell |
48,988
-2,035
| -4% | -$125K | 1.56% | 16 |
|
|
2017
Q3 | $3.25M | Buy |
51,023
+4,685
| +10% | +$299K | 1.81% | 12 |
|
|
2017
Q2 | $2.58M | Buy |
46,338
+1,430
| +3% | +$79.7K | 1.46% | 14 |
|
|
2017
Q1 | $2.44M | Buy |
44,908
+8,188
| +22% | +$445K | 1.46% | 14 |
|
|
2016
Q4 | $2.15M | Buy |
36,720
+6,221
| +20% | +$364K | 1.3% | 17 |
|
|
2016
Q3 | $1.65M | Buy |
30,499
+11,614
| +61% | +$626K | 1.04% | 21 |
|
|
2016
Q2 | $1.39M | Buy |
18,885
+14,615
| +342% | +$1.07M | 0.95% | 24 |
|
|
2016
Q1 | $273K | Buy |
+4,270
| New | +$273K | 0.19% | 45 |
|